Table 2.
Age (years) | Primary reason for referral | Primary results | Gene | Molecular diagnosis |
---|---|---|---|---|
prenatal | Cardiovascular | Positive | AARS2 (OMIM#612035; GenBank RefSeq NG_031952.1) | Combined oxidative phosphorylation deficiency 8 |
3 | Intellectual disability | Positive | FOXP1 (OMIM#605515; GenBank RefSeq NG_028243.1) | Intellectual disability with language impairment and with or without autistic features |
3 | Intellectual disability | Positive | SYNGAP1 (OMIM#603384; GenBank RefSeq NG_016137.2) | Mental retardation, autosomal dominant 5 |
2 | Multiple congenital anomalies | Positive | FBN1 (OMIM#134797; GenBank RefSeq NG_008805.2) | Type 1 Fibrillinopathy |
10 | Multiple congenital anomalies | Positive | KAT6B (OMIM#605880; GenBank RefSeq NG_032048.1) | Genitopatellar/Say‐Barber‐Biesecker‐Young‐Simpson syndrome |
2 | Multiple congenital anomalies | Partial positive | ACTG2 (OMIM#102545; GenBank RefSeq NG_034140.1) | Visceral myopathy |
2 | Neurodevelopmental | Positive | SLC16A2 (OMIM#300095; GenBank RefSeq NG_011641.1) | Allan‐Herndon‐Dudley syndrome |
2 | Neurodevelopmental | Positive | TCF4 (OMIM#602272; GenBank RefSeq NG_011716.2) | Pitt‐Hopkins syndrome |
8 | Neurodevelopmental | Likely positive | EP300 (OMIM#602700; GenBank RefSeq NG_009817.1) | Rubinstein‐Taybi syndrome |
2 | Neurodevelopmental | Likely positive | DDX3X (OMIM#300160; GenBank RefSeq NG_012830.2) | X‐linked intellectual disability 102 |
Positive | RAI1 (OMIM#607642; GenBank RefSeq NG_007101.2) | Smith‐Magenis syndrome | ||
1 | Neurodevelopmental | Positive | MECP2 (OMIM#300005; GenBank RefSeq NG_007107.2) | Encephalopathy, neonatal severe |
4 | Neurodevelopmental | Positive |
KDM5C (OMIM#314690; GenBank RefSeq NG_008085.2) MSH6 [Link] (OMIM#600678; GenBank RefSeq NG_007111.1) |
X‐linked Claes‐Jensen type syndromic mental retardation, Lynch syndrome |
3 | Neurodevelopmental | Positive | SLC2A1 (OMIM#138140; GenBank RefSeq NG_008232.1) | Stomatin‐deficient cryohydrocytosis with neurologic defects |
21 | Neurodevelopmental | Positive | FOXP1 (OMIM#605515; GenBank RefSeq NG_028243.1) | Intellectual disability with language impairment and with or without autistic features |
14 | Neurodevelopmental | Positive | ANKRD11 (OMIM#611192; GenBank RefSeq NG_032003.1) | KBG syndrome |
2 | Neurodevelopmental | Positive | SCN8A (OMIM#600702; GenBank RefSeq NG_021180.2) | Epileptic encephalopathy, early infantile, 13 |
1 | Neurodevelopmental | Positive | GABBR2 (OMIM#607340; GenBank RefSeq NG_016426.1) | GABBR2‐related neurodevelopmental disorder |
7 | Neurodevelopmental | Positive | UBE3A (OMIM#601623; GenBank RefSeq NG_009268.1) | Angelman syndrome |
17 | Neurodevelopmental | Positive | PMM2 (OMIM#601785; GenBank RefSeq NG_009209.1) | Congenital disorder of glycosylation, Type IA |
1 month. | Neuromuscular | Likely positive | SOX10 (OMIM#602229; GenBank RefSeq NG_007948.1) | SOX10‐related peripheral demyelinating neuropathy |
4 | Neuromuscular | Positive | TPM3 (OMIM#191030; GenBank RefSeq NG_008621.1) | TPM3‐related myopathy |
4 | Seizures | Likely positive | MEF2C (OMIM#600662; GenBank RefSeq NG_023427.1) | Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations |
2 | Cancer susceptibility, Multiple congenital disorders | Likely positive | SMARCE1 (OMIM#603111; GenBank RefSeq NG_032163.1) | Coffin‐Sirissyndrome |
Expanded positive | MSH6 (OMIM#600678; GenBank RefSeq NG_007111.1) | Increased risk of Lynch syndrome | ||
4 | Neurodevelopmental | Novel | ZBTB18 (OMIM#608433; GenBank RefSeq NG_033841.1) | ZBTB18‐related intellectual disability with hypogenesis of the corpus callosum |
5 | Autism | Uncertain | IQSEC2 (OMIM#300522; GenBank RefSeq NG_021296.2) | |
1 month | Cardiovascular | Uncertain | HCN4 (OMIM#605206; GenBank RefSeq NG_009063.1) | |
23 | Movement disorder | Uncertain | TPK1 (OMIM#606370; GenBank RefSeq NG_032112.1) | |
11 | Neurodevelopmental | Uncertain | SCN8A (OMIM#600702; GenBank RefSeq NG_021180.2) | |
8 | Seizures | Uncertain | DCX (OMIM#300121; GenBank RefSeq NG_011750.1) | |
11 | Seizures | Uncertain | SETBP1 (OMIM#611060;GenBank RefSeq NG_027527.2) | |
7 | Undergrowth | Positive[Link] | CACNA1S (OMIM#114208; GenBank RefSeq NG_009816.1) | Increased risk of malignant hyperthermia |
Secondary finding.